SCNX (Scienture Holdings) FCF Margin % : -5,488.68% (As of Dec. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Scienture Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Scienture Holdings's Free Cash Flow for the three months ended in Dec. 2024 was $-2.91 Mil. Scienture Holdings's Revenue for the three months ended in Dec. 2024 was $0.05 Mil. Therefore, Scienture Holdings's FCF Margin % for the quarter that ended in Dec. 2024 was -5,488.68%.

As of today, Scienture Holdings's current FCF Yield % is -163.33%.

The historical rank and industry rank for Scienture Holdings's FCF Margin % or its related term are showing as below:

SCNX' s FCF Margin % Range Over the Past 10 Years
Min: -10412.41 Med: -22.93 Max: 6.73
Current: -10412.41

During the past 13 years, the highest FCF Margin % of Scienture Holdings was 6.73%. The lowest was -10412.41%. And the median was -22.93%.

SCNX's FCF Margin % is ranked worse than
99.25% of 666 companies
in the Healthcare Providers & Services industry
Industry Median: 2.37 vs SCNX: -10412.41

Scienture Holdings FCF Margin % Historical Data

The historical data trend for Scienture Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scienture Holdings FCF Margin % Chart

Scienture Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

-13.16

-26.18

-19.67

-163.12

-10,412.41

Scienture Holdings Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial															-789.92	-	22,221.05	-8,289.23	-5,488.68

Competitive Comparison of Scienture Holdings's FCF Margin %

For the Pharmaceutical Retailers subindustry, Scienture Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Scienture Holdings's FCF Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Scienture Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Scienture Holdings's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Scienture Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Scienture Holdings's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-14.265	/	0.137
	=	-10,412.41 %

Scienture Holdings's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-2.909	/	0.053
	=	-5,488.68 %

Scienture Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of Scienture Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Scienture Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Scienture Holdings Inc (NAS:SCNX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

4E4:Germany

Address

2420 Brunello Trace, Lutz, FL, USA, 33558

Website

vhttps://www.scienture.com

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.

Executives

A. Jeffrey Newell	director	645 CAMP DIXIE RD, PASCOAG RI 02859
Donald G. Fell	director	17537 DARBY LANE, LUTZ FL 33558
Janet Huffman	officer: CFO, PAO, PFO	5317 FRUITVILLE RD SUITE 6, SARASOTA FL 34232
Michael L Peterson	director	17 CANARY COURT, DANVILLE CA 94526
Christine L. Jennings	director	3840 LAND O' LAKES BLVD., LAND O' LAKES FL 34639
Prashant Patel	director, 10 percent owner, officer: President	17537 DARBY LANE, LUTZ FL 33558
Pamela Tenaerts	director	PO BOX 15012, SARASOTA FL 34277
Gary Augusta	director	700 NORTH BRAND BLVD., SUITE 1400, GLENDALE CA 91203
Howard A. Doss	officer: CFO	17537 DARBY LANE, LUTZ FL 90067
Surendra K Ajjarapu	director, 10 percent owner, officer: CEO	8604 BUTTON BUSH CT, TAMPA FL 33647
Donald V. Almeida	director	1115 GUNN HIGHWAY, SUITE 202, ODESSA FL 33556
Charles L Pope	director	4902 EISENHOWER BOULEVARD, TAMPA FL 33634
Sandhya Ajjarapu	10 percent owner	17537 DARBY LANE, LUTZ FL 33558